Active Southbound Stock Connect Trading Highlights | December 9, 2025

Stock News12-09

On December 9, 2025, BABA-W (09988), XIAOMI-W (01810), and TENCENT (00700) topped the Shanghai-Hong Kong Stock Connect (Southbound) trading volume, with turnovers of RMB 4.115 billion, RMB 3.321 billion, and RMB 2.930 billion, respectively. Meanwhile, BABA-W (09988), TENCENT (00700), and SMIC (00981) led the Shenzhen-Hong Kong Stock Connect (Southbound) trading, recording turnovers of RMB 3.237 billion, RMB 1.987 billion, and RMB 1.503 billion, respectively.

**Top 10 Active Stocks in Shanghai-Hong Kong Stock Connect (Southbound)** - BABA-W (09988): RMB 4.115 billion (+RMB 83.45 million net inflow) - XIAOMI-W (01810): RMB 3.321 billion (+RMB 156 million net inflow) - TENCENT (00700): RMB 2.930 billion (+RMB 1.126 billion net inflow) - SMIC (00981): RMB 2.806 billion (-RMB 133 million net outflow) - POP MART (09992): RMB 1.880 billion (-RMB 438 million net outflow) - Agricultural Bank (01288): RMB 1.114 billion (+RMB 307 million net inflow) - CSOP Hang Seng TECH ETF (03033): RMB 1.084 billion (-RMB 44.28 million net outflow) - Hua Hong Semiconductor (01347): RMB 1.022 billion (+RMB 184 million net inflow) - Yangtze Optical Fibre (06869): RMB 880 million (+RMB 58.04 million net inflow) - China Construction Bank (00939): RMB 789 million (-RMB 47.48 million net outflow)

**Top 10 Active Stocks in Shenzhen-Hong Kong Stock Connect (Southbound)** - BABA-W (09988): RMB 3.237 billion (+RMB 342 million net inflow) - TENCENT (00700): RMB 1.987 billion (-RMB 248 million net outflow) - SMIC (00981): RMB 1.503 billion (+RMB 14.69 million net inflow) - XIAOMI-W (01810): RMB 1.203 billion (+RMB 384 million net inflow) - POP MART (09992): RMB 1.016 billion (-RMB 136 million net outflow) - Hua Hong Semiconductor (01347): RMB 596 million (+RMB 66.03 million net inflow) - CNOOC (00883): RMB 570 million (-RMB 44.24 million net outflow) - 3SBio (01530): RMB 553 million (-RMB 91.40 million net outflow) - Innovent Biologics (01801): RMB 506 million (+RMB 179 million net inflow) - Akeso Biopharma (09926): RMB 502 million (+RMB 43.19 million net inflow)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment